Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
2010 · The Journal of Immunology · 440 citations
https://doi.org/10.4049/jimmunol.0902819
P
Peggy Scherle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
386
Papers
16.7K
Citations
56
h-index
128
i10-index
Peggy Scherle is an academic researcher. The author has contributed to research in topics: Cancer-related gene regulation & Protein Degradation and Inhibitors & Chromatin Remodeling and Cancer. The author has an h-index of 56, co-authored 329 publications.
ORCID: 0000-0003-0783-6815Papers by this author
worksInhibition of Mitogen-Activated Protein Kinase Kinase Blocks T Cell Proliferation But Does Not Induce or Prevent Anergy
1998 · The Journal of Immunology · 294 citations
https://doi.org/10.4049/jimmunol.160.9.4175
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
2006 · Cancer Biology & Therapy · 184 citations
https://doi.org/10.4161/cbt.5.6.2708
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
2009 · Trends in Molecular Medicine · 174 citations
https://doi.org/10.1016/j.molmed.2009.11.005
Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells
1992 · The Journal of Immunology · 166 citations
https://doi.org/10.4049/jimmunol.148.1.212
Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
2008 · Cancer Research · 114 citations
https://doi.org/10.1158/0008-5472.can-08-0739
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat